SAMe in Prevention of Oxaliplatin-associated Liver Injury
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Not yet recruiting · NCT06258525 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SAMe in Prevention of Oxaliplatin-associated Liver Injury | 5-fluorouracil toxicity, Chemically-Induced Disorders, Chemically-Induced Liver Toxicity, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, cardiovascular disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, drug-induced liver injury, hepatic veno-occlusive disease, intestinal disorder, liver disorder, neoplasm, poisoning, rectal disorder, vascular disorder | Not yet recruiting | Phase 2 | 2026-09-30 | NCT06258525 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cedars-Sinai Medical Center | 161 |
| Jarrow Formulas Inc | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center at SOCC | Los Angeles | United States | 1 |
| Cedars-Sinai Medical Center Beverly Hills | Los Angeles | United States | 2 |